LIGAND PHARMACEUTICALS INC - COM NEW (LGND)

Q2 2021 13F Holders as of 6/30/2021

Type / Class
Equity / COM NEW
Number of holders
210
Total Shares
15.9M
Shares change
+458K
Total reported value, excl. options
$2.08B
Value change
+$57.3M
Put/Call ratio
0.43
Number of buys
88
Number of sells
-102
Price
$131.19
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.